Hims & Hers Health Public Company (NYSE:HIMS)

Primary contact

🚀 Merged with Oaktree Acquisition Corp. on January 20, 2021. in a SPAC deal worth $1.6B, raising $280M in the process.
Launched in November 2017, Hims & Hers Health offers a modern approach to health and wellness. The company's offering includes telehealth consultations, prescription and over-the-counter drugs, as well as personal care products for skin care, hair loss, and sexual health. The company's mission is to eliminate stigmas and make it easier for people to access care and treatment for the conditions that impact their daily lives.
Primary contact

Funding 💰

Total $233.2M
Select investors Franklin Templeton Investments, DCM Ventures, Founders Fund, Redpoint, Forerunner Ventures, SV Angel
Last update: September 4, 2021